Chances are you may have heard of CBD lately, it’s having a bit of a moment right now. Heck, even one of the Real Housewives just launched a CBD company and Sephora was offering a CBD mascara. As the hype grows, many are left to wonder the difference between fact and fiction when it comes to the benefits, effects, and legality. Like many other cannabis products, it has not been thoroughly studied due to prohibition, but with it’s increasing legal status that is changing. There is more and more scientific evidence supporting what benefits CBD has, but there is still a lot of misinformation out there. Many marketers play to the fact that the general public is uneducated on the topic. And let’s face it, it’s darn confusing! I’m here to help you wade through the murky CBD waters and come out the other side avoiding a lightened pocketbook wasting money on products that don’t work and frankly, just don’t make sense.
While 38 percent of women worldwide suffer from chronic diseases, only 4 percent of research and development funding goes toward examining women’s health-care products and services. This leads women to seek out and experiment with alternative therapies, cannabis among them.
“The female reproductive system has the highest concentration of endocannabinoid receptors after the brain, making women particularly responsive to the medicinal properties of the plant.”
Kanabé is pleased to announce that it has been acquired by EFX Laboratories.
EFx is a privately held cannabis company whose defined business strategy is wellness through cannabis. EFx is sponsoring a Health Canada submission of one of the first cannabis based Phase I & Phase III Clinical studies measuring cannabis as a viable post-operative treatment. EFx also currently contract manufactures two piece medical cannabis pills for Broken Coast Cannabis Ltd (“BCC”) and Aphria Inc. (“Aphria”).